Oruka Therapeutics (ORKA) Interest Coverage Ratio (QoQ) (2010 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -127.86% |
| Jun 30, 2020 | -30.35% |
| Sep 30, 2019 | -148.08% |
| Jun 30, 2019 | 15.33% |
| Sep 30, 2018 | -15.63% |
| Jun 30, 2018 | 22.25% |
| Sep 30, 2017 | 19.50% |
| Jun 30, 2017 | -26.89% |
| Sep 30, 2015 | -107.21% |
| Jun 30, 2015 | 50.46% |
| Sep 30, 2014 | 5.03% |
| Jun 30, 2014 | -0.67% |
| Mar 31, 2014 | 18.90% |
| Jun 30, 2013 | 44.02% |
| Sep 30, 2012 | -62.10% |
| Jun 30, 2012 | 59.28% |
| Mar 31, 2012 | -444.19% |
| Dec 31, 2011 | 144.87% |
| Sep 30, 2011 | -6.87% |
| Jun 30, 2011 | -93.46% |
| Mar 31, 2011 | 81.28% |
| Dec 31, 2010 | -235.04% |
| Sep 30, 2010 | 38.12% |